Cardiovascular pathology in rheumatoid arthritis

Terapevticheskii Arkhiv

Volumn 79, Issue 5, 2007, Pages 9-14

  Popkova, T V ^a   Khelkovskaya, A N ^a   Mach, E S ^a   Aleksandrova, E N ^a   Novikov, A A ^a   Novikova, D S ^a   Nasonov, E L ^a  

^a NONE

Author keywords

Atherosclerosis; Cardiovascular risk factors; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; CAROTID ARTERY; ECHOGRAPHY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PREDICTION AND FORECASTING; RHEUMATOID ARTHRITIS; RISK FACTOR;

ADULT; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CHOLESTEROL; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TRIGLYCERIDES;

EID: 34547432995     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Russian source
2. Goodson N. Coronary artery disease and rheumatoid arthritis. Curr. Opin. Rheumatol. 2002; 14: 115-120.
3. Pincus T., Sokka T., Wolfe F. Premature mortality in patients with rheumatoid arthritis: evolving concepts. Arthr. and Rheum. 2001; 44: 1234-1236.
4. Van Dorum S., McColl G., Wicks I. P. Accelerated atherosclerosis. An extraarticular feature of rheumatoid arthritis. Arthr. and Rheum. 2002; 46: 862-875.
5. Kitas G. D., Erb N. Tackling ischemic heart disease in rheumatoid arthritis. Rheumatology 2003; 42: 607-613.
6. Boers M., Dijkmans B., Gabriel S. et al. Making an impact on mortality in rheumatoid arthritis. Targeting cardiovascular comorbidity. Arthr. and Rheum. 2004; 50: 1734-1739.
7. Wang T. J., Nam B.-H., Wilson P. W. F. et al. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler. Thromb. Vase. Biol. 2002; 22: 1662-1667.
8. Cao J. I., Thach C., Manolio T. A. et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly. Circulation 2003; 108: 166-170.
9. O'Leary D. H., Polak J. F., Kronmal R. A. et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 1999; 340: 14-22.
10. Winbeck K., Kukla C., Poppert H. et al. Elevated C-reactive protein is associated with an increased intima to media thickness of the common carotid artery. Cerebrovasc. Dis. 2002; 13: 57-63.
11. Bots M. L., Hoes A. W., Koudstaal P. J. et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction. Circulation 1997; 96: 1432-1437.
12. Park Y.-B., Ahn C.-W., Choi H. K. et al. Atherosclerosis in rheumatoid arthritis. Morphologic evidence obtained by carotid ultrasound. Arthr. and Rheum. 2002; 46 (7): 1714-1719.
13. Chung C. P., Oeser A., Raggi P. et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis. Arthr. and Rheum. 2005; 52 (10): 3045-3053.
14. Bonetti P. O., Leman L. O., Leman A. Endothelial dysfunction. A marker of atherosclerotic risk. Arterioscler. Thromb. Vase. Biol. 2003; 23: 168-175.
15. Del Rincon I., Williams K, Stern M. P. et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthr. and Rheum. 2001; 44: 2737-2745.
16. Gabriel S. E., Crowson C. S., Kremers H. M. et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthr. and Rheum. 2003; 48: 54-58.
17. Fischer L. M., Schlienger R. G., Matter C. et al. Effects of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am. J. Cardiol. 2004; 93: 198-200.
18. Pasceri V., Yeh E. T. H. A tale of two diseases. Atherosclerosis and rheumatoid arthritis. Circulation 1999; 100: 2124-2126.
19. Sattar N., McCrey D. W., Capell H., McInnes I. B. Explaining how "high-grade" systemic inflammation accelerated vascular risk in rheumatoid arthritis. Circulation 2003; 108: 2957-2963.
20. Russian source
21. Shoenfeld Y., Harals D., Wiek G. et al. Atherosclerosis and autoimmunity. Amsterdam: Elsevier; 2001.
22. Russian source
23. Svmitko P. E., Wang C. H, Weisel R. D. et al. New markers of inflammation and endothelial cell activation, part I. Circulation 2003; 108: 1917-1923.
24. Szmitko P. E., Wang C. H., Weisel R. D. et al. New markers of inflammation and endothelial cell activation, part II. Circulation 2003; 108: 2041-2048.
25. Russian source
26. Roberts W. L., Moulton L., Law T. C. et al. Evaluation of nine automated high sensitive C-reactive protein methods: implications for clinical and epidemiological applications. Clin. Chem. 2000; 47: 418-423.
27. Ridker P. M. High-sensitive C-reactive protein. Potential adjunct for global risk assessment in the primery prevention of cardiovascular disease. Circulation 2001; 103: 357-362.
28. Tracy R. P. Inflammation markers and coronary heart disease. Curr. Opin. Lipidol. 1999; 10: 435-441.
29. Lagrand W. K, Visser C. A., Hermens W. T. et al. C-reactive protein as cardiovascular risk factor: more than an epiphenomenoma. Circulation 1999; 100: 96-102.
30. Russian source
31. Amertt F. C., Edworthy S. M., Bloch D. A. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr. and Rheum. 1988; 3: 315-324.
32. Russian source
33. Artiss J. D., Zak B. Measurement of cholesterol concentration. In: Rifai N., Warmic G. R., Dominiczak M. H., eds. Handbook of lipoprotein testing. Washington: AACC Press; 1997. 99-114.
34. Friedwald W. T., Levy R. J., Fredrickson D. S. Estimation of the calculation of LDL cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499-502.
35. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Summary of the second report of the national cholesterol education program (NCEP) expert panel detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). J. A. M. A. 1993; 269: 3015-3023.
36. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the 3-rd report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J. A. M. A. 2001; 285: 2486-2497.
37. Russian source
38. Howard G., Sharrett A. R., Heiss G. et al. Carotid artery intima-media thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993; 24: 1297-1304.
39. Iannuzzi A., Michele M. D., Panico S. et al. Radical-trapping activity, blood pressure, and carotid enlargement in women. Hypertension 2003; 41: 289-296.
40. Del Rincon L, Williams K, Stern M. P. et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthr. and Rheum. 2001; 44: 2737-2745.
41. Dessein P. H., Joffe B. I., Veller M. G. et al. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J. Rheumatol. 2005; 32: 435-442.
42. Mikuls T. R., Saag K. G. Comorbidity in rheumatoid arthritis. Rheum. Dis. Clin. N. Am. 2001; 27: 283-303.
43. McEntegart A., Capell H. A., Creran D. et al. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology 2001; 40: 640-644.
44. Alkaabi J. K, Ho M., Levison R. et al. Rheumatoid arthritis and macrovascular disease. Rheumatology 2003; 42: 292-297.
45. Situnayake R. D., Kitas G. Dyslipidemia and rheumatoid arthritis. Ann. Rheum. Dis. 1997; 56: 341-342.
46. Svenson K. L., Lithell H., Hallgren R. et al. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch. Intern. Med. 1987; 147: 1912-1916.
47. Lacatos I., Harsagyi A. Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis. Clin. Biochem. 1988; 21: 93-96.
48. Lazarevic M. B., Vitic I., Mladenovic V. Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin. Arthr. Rheum. 1992; 22: 172-178.
49. Hashimoto H, Kitagawa K, Hougaku H. et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001; 104: 63-67.
50. Kumeda Y., Inaba M., Goto H. et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthr. and Rheum. 2002; 46 (6): 1489-1497.
51. Gerli R., Sherer Y., Vaudo G. et al. Early atherosclerosis in rheumatoid arthritis. Effect of smoking on thickness of the carotid artery intima media. Ann. N. Y. Acad. Sci. 2005; 1015: 281-290.
52. Roman M. J., Moeller E., Davis A. et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann. Intern. Med. 2006; 144: 249-256.
53. Russian source
54. Russian source
55. Ridker P. M., Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Score. Circulation 2004; 109: 1955-1959.
56. Del Rincon I., Williams K., Stem M. et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthr. and Rheum. 2003; 48 (7): 1833-1840.
57. Gonzales-Juanatey C., Liorca J., Testa A. et al. Increased prevalence of severe subclinical atherosclerotic findings in longterm treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003; 82: 407-413.
58. Nagata-Sakurai M., Inaba M., Goto H. et al. Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthr. and Rheum. 2003; 48: 3061-3067.
59. Gonzalez-Gay M. A., Gonzalez-Junatey C., Pineiro A. et al. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J. Rheumatol. 2005; 32: 1219-1223.